Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), Department of Chemistry, Wuhan University, Wuhan 430072, China.
Anal Chem. 2021 Jan 19;93(2):737-744. doi: 10.1021/acs.analchem.0c02455. Epub 2020 Dec 7.
Quantification of multiple disease-related microRNAs (miRNAs) is of great significance for clinical diagnosis. Based on the simultaneous multiple element detection ability of inductively coupled plasma-mass spectrometry (ICP-MS) and good specificity of multicomponent nucleic acid enzymes (MNAzymes), a novel and simple method based on the MNAzyme amplification strategy and lanthanide labeling coupled with ICP-MS detection was proposed for the sensitive and simultaneous detection of three miRNAs (miRNA-21, miRNA-155, and miRNA-10b). Specifically, a probe consisting of streptavidin-modified magnetic beads (SA-MBs) and three DNA substrates labeled with lanthanide tags (Tb/Ho/Lu) was constructed. In the presence of target miRNAs, three pairs of MNAzymes were assembled where each pair was hybridized with the corresponding miRNA, and then the substrates on the SA-MBs were cleaved by the activated MNAzymes, continuously releasing the fragment with lanthanide tags. The released lanthanide tags in the supernatant were collected after magnetic separation and analyzed by ICP-MS, realizing the simultaneous quantification of multiple miRNAs. The correlation of the lanthanide tag signal with the miRNA concentration fitted well in a linear model in the range of 50-1000 pmol L (miRNA-21) and 50-2000 pmol L (miRNA-155 and miRNA-10b). The limits of detection for three miRNAs were 11-20 pmol L, with the relative standard deviations of 2.2-2.7%. The recoveries of target miRNAs in the human serum and HepG-2 cells were in the range of 87.2-111% and 93.3-111%, respectively. Overall, the method is ideal for the simultaneous quantification of multiple miRNAs with advantages of low spectral interference, high sensitivity, good selectivity, and strong resistance to the complex matrix.
定量检测多种疾病相关 microRNA(miRNA)对于临床诊断具有重要意义。基于电感耦合等离子体质谱(ICP-MS)的同时多元素检测能力和多组分核酸酶(MNAzyme)的良好特异性,提出了一种基于 MNAzyme 扩增策略和镧系元素标记与 ICP-MS 检测相结合的新型简单方法,用于灵敏且同时检测三种 miRNA(miRNA-21、miRNA-155 和 miRNA-10b)。具体来说,构建了由链霉亲和素修饰的磁性珠(SA-MB)和三种用镧系元素标签(Tb/Ho/Lu)标记的 DNA 底物组成的探针。在存在靶 miRNA 的情况下,组装了三对 MNAzyme,每对与相应的 miRNA 杂交,然后 SA-MB 上的底物被激活的 MNAzyme 切割,连续释放带有镧系元素标签的片段。磁分离后收集上清液中的释放的镧系元素标签,并通过 ICP-MS 进行分析,实现了多种 miRNA 的同时定量。镧系元素标签信号与 miRNA 浓度之间的相关性在 50-1000 pmol L(miRNA-21)和 50-2000 pmol L(miRNA-155 和 miRNA-10b)范围内拟合良好的线性模型。三种 miRNA 的检测限为 11-20 pmol L,相对标准偏差为 2.2-2.7%。人血清和 HepG-2 细胞中目标 miRNA 的回收率在 87.2-111%和 93.3-111%之间。总的来说,该方法对于多种 miRNA 的同时定量具有理想的效果,具有光谱干扰低、灵敏度高、选择性好、抗复杂基质能力强等优点。